Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB
Mandate

Vinge advises Stiftelsen Industrifonden on the investment in Airsonett AB

August 23, 2007

Industrifonden and SEB will make a joint investment of MSEK 55 and the existing shareholders will invest the remaining MSEK 15 in Airsonett AB, a medical technology company. Airsonett AB carries out research and develops non-pharmaceutical aids reducing the allergen and other air pollution.

Stiftelsen Industrifonden is represented by partner Johan Winnerblad and Johan Larsson.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025